Dr. Peter R. Baker II, MD
Medical Genetics (Clinical Genetics (M.D.) Physician)
13123 E 16th Ave
Aurora, CO 80045
Who else practices at this address →
Adams County includes primary care (2% of residents) shortage areas. About shortage areas
At a glance
- Medical school
- University of Arizona College of Medicine (2005)
- Years since graduation
- 21
- In the NPI registry since
- 2007
Licensed in Colorado since 2008, according to the Colorado Department of Regulatory Agencies. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2005Medical school: University of Arizona College of Medicine
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Clinical Genetics (M.D.) Physician primary
CO license 47103 (first issued 2008; active) · MT license 174432 -
Pediatrics Physician
CO license 47103 (first issued 2008; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- University Physicians Incorporated (3,215 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Levocarnitine (levocarnitine (with sugar)) | 14 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 1 companies reported 1 payments worth $32.90 in total to this clinician.
| Cycle Pharmaceuticals Inc | $32.90 |
|---|
| Food and Beverage | $32.90 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $61,548 in research payments for these studies, mostly to the institutions running them.
- Long-Chain Fatty Acid Oxidation Disorders In-Clinic Disease Monitoring Program
Ultragenyx Pharmaceutical Inc. · Active, not recruiting · NCT04632953 - US-Based Retrospective Medical Record Review of Patients with Methylmalonic Acidemia (MMA) Undergoing Liver or Combined Liver-Kidney Transplants (LT/LKT)
ModernaTX, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.